Thousands of individuals may undergo intricate surgery to eliminate risky spinal implants. Patients with injured neck discs were provided M6-C artificial implants as a safer alternative to metal rod spinal fusion. However, this device has been associated with osteolysis, a degenerative condition that destroys and reabsorbs bone tissue.
Penningtons Manches Cooper, a law firm, has been contacted by a minimum of 10 individuals facing complications, including Sophia Harrison, 52. After receiving the implant in 2019, Sophia developed symptoms like pins and needles and a throat lump. Subsequent tests revealed osteolysis, leading to potential removal of the implant and additional discs.
Expressing her concerns, Sophia urged others with the implant to undergo scans promptly to avert similar consequences. Australian regulators issued a warning on bone loss linked to the M6-C disc in 2020, while UK patients were informed six years later. This delay has left patients like Sophia feeling frustrated and facing complex spinal surgeries.
Sophia’s legal representative, Lyndsey Skibinski, emphasized the need for thorough monitoring and potential implant removal due to associated risks. The MHRA acknowledged the delay in communicating osteolysis risks and stressed the importance of patient safety and regular monitoring.
Dr. Stephanie Millican from the MHRA urged healthcare professionals to inform M6-C implant recipients about the risks, conduct routine monitoring, and consider further investigation. Patients and caregivers were encouraged to report any suspected side effects via the Yellow Card scheme for enhanced safety measures.
